{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:05:32Z","timestamp":1792807532098,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T00:00:00Z","timestamp":1326931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s11606-011-1966-4","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T18:09:22Z","timestamp":1326910162000},"page":"853-860","source":"Crossref","is-referenced-by-count":76,"title":["Symptomatic and Palliative Care for Stroke Survivors"],"prefix":"10.1007","volume":"27","author":[{"given":"Claire J.","family":"Creutzfeldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,19]]},"reference":[{"key":"1966_CR1","volume-title":"Heart Disease and Stroke Statistics \u2013 2010 Update","author":"AHA\/ASA","year":"2010","unstructured":"AHA\/ASA. Heart Disease and Stroke Statistics \u2013 2010 Update; 2010."},{"key":"1966_CR2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","volume":"38","author":"HP Adams Jr","year":"2007","unstructured":"Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association\/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655\u20131711.","journal-title":"Stroke"},{"key":"1966_CR3","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/STR.0b013e3181ec611b","volume":"41","author":"LB Morgenstern","year":"2010","unstructured":"Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2010;41:2108\u20132129.","journal-title":"Stroke"},{"key":"1966_CR4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1474-4422(09)70150-4","volume":"8","author":"P Langhorne","year":"2009","unstructured":"Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol. 2009;8:741\u2013754.","journal-title":"Lancet Neurol"},{"key":"1966_CR5","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(11)60325-5","volume":"377","author":"P Langhorne","year":"2011","unstructured":"Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet. 2011;377:1693\u20131702.","journal-title":"Lancet"},{"key":"1966_CR6","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1161\/01.STR.0000180861.54180.FF","volume":"36","author":"PW Duncan","year":"2005","unstructured":"Duncan PW, Zorowitz R, Bates B, et al. Management of Adult Stroke Rehabilitation Care: a clinical practice guideline. Stroke. 2005;36:e100\u2013e143.","journal-title":"Stroke"},{"key":"1966_CR7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0269216307079160","volume":"21","author":"T Stevens","year":"2007","unstructured":"Stevens T, Payne SA, Burton C, Addington-Hall J, Jones A. Palliative care in stroke: a critical review of the literature. Palliat Med. 2007;21:323\u2013331.","journal-title":"Palliat Med"},{"key":"1966_CR8","volume-title":"Clinical Practice Guideline Process Manual. online","author":"WGG Edlund","year":"2004","unstructured":"Edlund WGG, So Y, Franklin G. Clinical Practice Guideline Process Manual. online; 2004."},{"key":"1966_CR9","unstructured":"WHO. Available at: http:\/\/www.who.int\/cancer\/palliative\/definition\/en\/ . Accessed 12\/07\/2011."},{"key":"1966_CR10","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/01.STR.28.10.1867","volume":"28","author":"E Kehayia","year":"1997","unstructured":"Kehayia E, Korner-Bitensky N, Singer F, et al. Differences in pain medication use in stroke patients with aphasia and without aphasia. Stroke. 1997;28:1867\u20131870.","journal-title":"Stroke"},{"key":"1966_CR11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp.2005.079145","volume":"77","author":"AC J\u00f6nsson","year":"2006","unstructured":"J\u00f6nsson AC, Lindgren I, Hallstr\u00f6m B, Norrving B, Lindgren A. Prevalence and intensity of pain after stroke: a population based study focusing on patients\u2019 perspectives. J Neurol Neurosurg Psychiatry. 2006;77:590\u2013595.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1966_CR12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1474-4422(09)70176-0","volume":"8","author":"H Klit","year":"2009","unstructured":"Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol. 2009;8:857\u2013868.","journal-title":"Lancet Neurol"},{"key":"1966_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0304-3959(89)90108-5","volume":"36","author":"G Leijon","year":"1989","unstructured":"Leijon G, Boivie J. Central post-stroke pain\u2014a controlled trial of amitriptyline and carbamazepine. Pain. 1989;36:27\u201336.","journal-title":"Pain"},{"key":"1966_CR14","first-page":"CD005454","volume":"4","author":"T Saarto","year":"2007","unstructured":"Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;4:CD005454.","journal-title":"Cochrane Database Syst Rev"},{"key":"1966_CR15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1212\/WNL.56.2.184","volume":"56","author":"K Vestergaard","year":"2001","unstructured":"Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001;56:184\u2013190.","journal-title":"Neurology"},{"key":"1966_CR16","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.pain.2010.12.023","volume":"152","author":"JS Kim","year":"2011","unstructured":"Kim JS, Bashford G, Murphy TK, Martin A, Dror V, Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain. 2011;152:1018\u20131023.","journal-title":"Pain"},{"key":"1966_CR17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0304-3959(02)00255-5","volume":"99","author":"MG Serpell","year":"2002","unstructured":"Serpell MG, Neuropathic pain study group. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002;99:557\u2013566.","journal-title":"Pain"},{"key":"1966_CR18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.ajp.0000173020.10483.13","volume":"22","author":"A Frese","year":"2006","unstructured":"Frese A, Husstedt IW, Ringelstein EB, Evers S. Pharmacologic treatment of central post-stroke pain. Clin J Pain. 2006;22:252\u2013260.","journal-title":"Clin J Pain"},{"key":"1966_CR19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/01.STR.0000254598.16739.4e","volume":"38","author":"I Lindgren","year":"2007","unstructured":"Lindgren I, Jonsson AC, Norrving B, Lindgren A. Shoulder pain after stroke: a prospective population-based study. Stroke. 2007;38:343\u2013348.","journal-title":"Stroke"},{"key":"1966_CR20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1191\/0269215504cr843oa","volume":"18","author":"RP Peppen Van","year":"2004","unstructured":"Van Peppen RP, Kwakkel G, Wood-Dauphinee S, Hendriks HJ, Van der Wees PJ, Dekker J. The impact of physical therapy on functional outcomes after stroke: what\u2019s the evidence? Clin Rehabil. 2004;18:833\u2013862.","journal-title":"Clin Rehabil"},{"key":"1966_CR21","first-page":"CD008271","volume":"9","author":"JA Singh","year":"2010","unstructured":"Singh JA, Fitzgerald PM. Botulinum toxin for shoulder pain. Cochrane Database Syst Rev. 2010;9:CD008271.","journal-title":"Cochrane Database Syst Rev"},{"key":"1966_CR22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/09638280903127685","volume":"32","author":"YH Koog","year":"2010","unstructured":"Koog YH, Jin SS, Yoon K, Min BI. Interventions for hemiplegic shoulder pain: systematic review of randomised controlled trials. Disabil Rehabil. 2010;32:282\u2013291.","journal-title":"Disabil Rehabil"},{"key":"1966_CR23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1090-3801(02)00055-1","volume":"6","author":"GE Gamble","year":"2002","unstructured":"Gamble GE, Barberan E, Laasch HU, Bowsher D, Tyrrell PJ, Jones AK. Poststroke shoulder pain: a prospective study of the association and risk factors in 152 patients from a consecutive cohort of 205 patients presenting with stroke. Eur J Pain. 2002;6:467\u2013474.","journal-title":"Eur J Pain"},{"key":"1966_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/NRE-2010-0596","volume":"27","author":"E Lapeyre","year":"2010","unstructured":"Lapeyre E, Kuks JB, Meijler WJ. Spasticity: revisiting the role and the individual value of several pharmacological treatments. NeuroRehabilitation. 2010;27:193\u2013200.","journal-title":"NeuroRehabilitation"},{"key":"1966_CR25","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/STROKEAHA.110.582197","volume":"42","author":"LC Shaw","year":"2011","unstructured":"Shaw LC, Price CI, van Wijck FM, et al. Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain. Stroke. 2011;42:1371\u20131379.","journal-title":"Stroke"},{"key":"1966_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MRR.0b013e328010c7b8","volume":"29","author":"P Appelros","year":"2006","unstructured":"Appelros P. Prevalence and predictors of pain and fatigue after stroke: a population-based study. Int J Rehabil Res. 2006;29:329\u2013333.","journal-title":"Int J Rehabil Res"},{"key":"1966_CR27","doi-asserted-by":"crossref","first-page":"e16988","DOI":"10.1371\/journal.pone.0016988","volume":"6","author":"GE Mead","year":"2011","unstructured":"Mead GE, Graham C, Dorman P, Bruins SK, Lewis SC, Dennis MS, Sandercock PA. UK Collaborators of IST. Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial. PLoS One. 2011;6:e16988.","journal-title":"PLoS One"},{"key":"1966_CR28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/STROKEAHA.108.527101","volume":"40","author":"C Winward","year":"2009","unstructured":"Winward C, Sackley C, Metha Z, Rothwell PM. A population-based study of the prevalence of fatigue after transient ischemic attack and minor stroke. Stroke. 2009;40:757\u2013761.","journal-title":"Stroke"},{"key":"1966_CR29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/oti.286","volume":"17","author":"NA Flinn","year":"2010","unstructured":"Flinn NA, Stube JE. Post-stroke fatigue: qualitative study of three focus groups. Occup Ther Int. 2010;17:81\u201391.","journal-title":"Occup Ther Int"},{"key":"1966_CR30","doi-asserted-by":"crossref","unstructured":"McGeough E, Pollock A, Smith LN, et al. Interventions for post-stroke fatigue. Cochrane Database Syst Rev 2009:CD007030.","DOI":"10.1002\/14651858.CD007030.pub2"},{"key":"1966_CR31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000232927","volume":"62","author":"A Brioschi","year":"2009","unstructured":"Brioschi A, Gramigna S, Werth E, et al. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol. 2009;62:243\u2013249.","journal-title":"Eur Neurol"},{"key":"1966_CR32","unstructured":"Peuckmann V, Elsner F, Krumm N, Trottenberg P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2010:CD006788."},{"key":"1966_CR33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.STR.28.1.58","volume":"28","author":"H Nakayama","year":"1997","unstructured":"Nakayama H, Jorgensen HS, Pedersen PM, Raaschou HO, Olsen TS. Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study. Stroke. 1997;28:58\u201362.","journal-title":"Stroke"},{"key":"1966_CR34","doi-asserted-by":"crossref","unstructured":"Thomas LH, Cross S, Barrett J, et al. Treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev 2008:CD004462.","DOI":"10.1002\/14651858.CD004462.pub3"},{"key":"1966_CR35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/CIA.S8100","volume":"5","author":"SS Rao","year":"2010","unstructured":"Rao SS, Go JT. Update on the management of constipation in the elderly: new treatment options. Clin Interv Aging. 2010;5:163\u2013171.","journal-title":"Clin Interv Aging"},{"key":"1966_CR36","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archneur.57.11.1617","volume":"57","author":"CF Bladin","year":"2000","unstructured":"Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57:1617\u20131622.","journal-title":"Arch Neurol"},{"key":"1966_CR37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000008120","volume":"43","author":"S Berges","year":"2000","unstructured":"Berges S, Moulin T, Berger E, et al. Seizures and epilepsy following strokes: recurrence factors. Eur Neurol. 2000;43:3\u20138.","journal-title":"Eur Neurol"},{"key":"1966_CR38","doi-asserted-by":"crossref","unstructured":"Kwan J, Wood E. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Syst Rev 2010:CD005398","DOI":"10.1002\/14651858.CD005398.pub2"},{"key":"1966_CR39","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.67.12_suppl_4.S3","volume":"67","author":"P Ryvlin","year":"2006","unstructured":"Ryvlin P, Montavont A, Nighoghossian N. Optimizing therapy of seizures in stroke patients. Neurology. 2006;67:S3\u2013S9.","journal-title":"Neurology"},{"issue":"5","key":"1966_CR40","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1474-4422(11)70047-3","volume":"10","author":"E Perucca","year":"2011","unstructured":"Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011;10(5):446\u2013456.","journal-title":"Lancet Neurol"},{"key":"1966_CR41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1468-1331.2008.02184.x","volume":"15","author":"Y Tamam","year":"2008","unstructured":"Tamam Y, Tamam L, Akil E, Yasan A, Tamam B. Post-stroke sexual functioning in first stroke patients. Eur J Neurol. 2008;15:660\u2013666.","journal-title":"Eur J Neurol"},{"key":"1966_CR42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/j.2048-7940.2007.tb00160.x","volume":"32","author":"DD Kautz","year":"2007","unstructured":"Kautz DD. Hope for love: practical advice for intimacy and sex after stroke. Rehabil Nurs. 2007;32:95\u2013103.","journal-title":"Rehabil Nurs"},{"key":"1966_CR43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.01.007","volume":"18","author":"B Silver","year":"2009","unstructured":"Silver B, McCarthy S, Lu M, et al. Sildenafil treatment of subacute ischemic stroke: a safety study at 25-mg daily for 2 weeks. J Stroke Cerebrovasc Dis. 2009;18:381\u2013383.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1966_CR44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/WNL.0b013e3181bd137c","volume":"73","author":"DM Hermann","year":"2009","unstructured":"Hermann DM, Bassetti CL. Sleep-related breathing and sleep-wake disturbanes in ischemic stroke. Neurology. 2009;73:1313\u20131322.","journal-title":"Neurology"},{"key":"1966_CR45","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1161\/STROKEAHA.110.596759","volume":"41","author":"W Chan","year":"2010","unstructured":"Chan W, Coutts SB, Hanly P. Sleep apnea in patients with transient ischemic attack and minor stroke: opportunity for risk reduction of recurrent stroke? Stroke. 2010;41:2973\u20132975.","journal-title":"Stroke"},{"key":"1966_CR46","doi-asserted-by":"crossref","unstructured":"Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008:CD003437.","DOI":"10.1002\/14651858.CD003437.pub3"},{"key":"1966_CR47","doi-asserted-by":"crossref","unstructured":"Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2008:CD003689.","DOI":"10.1002\/14651858.CD003689.pub3"},{"key":"1966_CR48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(10)70314-8","volume":"10","author":"F Chollet","year":"2011","unstructured":"Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10:123\u2013130.","journal-title":"Lancet Neurol"},{"key":"1966_CR49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.archger.2004.09.004","volume":"40","author":"L Rampello","year":"2005","unstructured":"Rampello L, Alvano A, Chiechio S, Raffaele R, Vecchio I, Malaguarnera M. An evaluation of efficacy and safety of reboxetine in elderly patients affected by \u201cretarded\u201d post-stroke depression. A random, placebo-controlled study. Arch Gerontol Geriatr. 2005;40:275\u2013285.","journal-title":"Arch Gerontol Geriatr"},{"key":"1966_CR50","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/STROKEAHA.109.549808","volume":"40","author":"PH Mitchell","year":"2009","unstructured":"Mitchell PH, Veith RC, Becker KJ, et al. Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial. Stroke. 2009;40:3073\u20133078.","journal-title":"Stroke"},{"key":"1966_CR51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005053-199302000-00005","volume":"181","author":"CS Castillo","year":"1993","unstructured":"Castillo CS, Starkstein SE, Fedoroff JP, Price TR, Robinson RG. Generalized anxiety disorder after stroke. J Nerv Ment Dis. 1993;181:100\u2013106.","journal-title":"J Nerv Ment Dis"},{"key":"1966_CR52","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.STR.25.6.1099","volume":"25","author":"G Andersen","year":"1994","unstructured":"Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke. 1994;25:1099\u20131104.","journal-title":"Stroke"},{"key":"1966_CR53","doi-asserted-by":"crossref","unstructured":"Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for delirium. Cochrane Database Syst Rev 2007:CD005594.","DOI":"10.1002\/14651858.CD005594.pub2"},{"key":"1966_CR54","doi-asserted-by":"crossref","unstructured":"House AO, Hackett ML, Anderson CS, Horrocks JA. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev 2010:CD003690.","DOI":"10.1002\/14651858.CD003690.pub3"},{"key":"1966_CR55","unstructured":"Dextromethorphan\/Quinidine (nuedexta) for pseudobulbar affect. Med Lett Drugs Ther. 2011;53:46\u201347"},{"key":"1966_CR56","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1191\/0269215501cr446oa","volume":"15","author":"ET Heuvel Van den","year":"2001","unstructured":"Van den Heuvel ET, de Witte LP, Schure LM, Sanderman R. Meyboom-de Jong B. Risk factors for burn-out in caregivers of stroke patients, and possibilities for intervention. Clin Rehabil. 2001;15:669\u2013677.","journal-title":"Clin Rehabil"},{"key":"1966_CR57","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1161\/01.STR.30.7.1478","volume":"30","author":"B Han","year":"1999","unstructured":"Han B, Haley WE. Family caregiving for patients with stroke. Review and analysis. Stroke. 1999;30:1478\u20131485.","journal-title":"Stroke"},{"key":"1966_CR58","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/bmj.328.7448.1099","volume":"328","author":"L Kalra","year":"2004","unstructured":"Kalra L, Evans A, Perez I, et al. Training carers of stroke patients: randomised controlled trial. BMJ. 2004;328:1099.","journal-title":"BMJ"},{"key":"1966_CR59","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/jpm.2009.0142","volume":"12","author":"C Puchalski","year":"2009","unstructured":"Puchalski C, Ferrell B, Virani R, et al. Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference. J Palliat Med. 2009;12:885\u2013904.","journal-title":"J Palliat Med"},{"key":"1966_CR60","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archinte.159.15.1803","volume":"159","author":"JW Ehman","year":"1999","unstructured":"Ehman JW, Ott BB, Short TH, Ciampa RC, Hansen-Flaschen J. Do patients want physicians to inquire about their spiritual or religious beliefs if they become gravely ill? Arch Intern Med. 1999;159:1803\u20131806.","journal-title":"Arch Intern Med"},{"key":"1966_CR61","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.1997.03550230075041","volume":"278","author":"TE Quill","year":"1997","unstructured":"Quill TE, Lo B, Brock DW. Palliative options of last resort: a comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia. JAMA. 1997;278:2099\u20132104.","journal-title":"JAMA"},{"key":"1966_CR62","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1176\/appi.ajp.157.3.351","volume":"157","author":"RG Robinson","year":"2000","unstructured":"Robinson RG, Schultz SK, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry. 2000;157:351\u2013359.","journal-title":"Am J Psychiatry"},{"key":"1966_CR63","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/01.STR.31.8.1829","volume":"31","author":"L Wiart","year":"2000","unstructured":"Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000;31:1829\u20131832.","journal-title":"Stroke"},{"key":"1966_CR64","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/acm.2008.0010","volume":"14","author":"LT Li","year":"2008","unstructured":"Li LT, Wang SH, Ge HY, Chen J, Yue SW, Yu M. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post- stroke depression. J Altern Complement Med. 2008;14:841\u2013846.","journal-title":"J Altern Complement Med"},{"key":"1966_CR65","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00415-003-1014-3","volume":"250","author":"S Fruehwald","year":"2003","unstructured":"Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of post-stroke depression\u2014a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol. 2003;250:347\u2013351.","journal-title":"J Neurol"},{"key":"1966_CR66","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4088\/JCP.v66n0606","volume":"66","author":"V Murray","year":"2005","unstructured":"Murray V, von Arbin M, Bartfai A, et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry. 2005;66:708\u2013716.","journal-title":"J Clin Psychiatry"},{"key":"1966_CR67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1176\/appi.neuropsych.20.2.178","volume":"20","author":"RG Robinson","year":"2008","unstructured":"Robinson RG, Jorge RE, Clarence-Smith K. Double-blind randomized treatment of poststroke depression using nefiracetam. J Neuropsychiatry Clin Neurosci. 2008;20:178\u2013184.","journal-title":"J Neuropsychiatry Clin Neurosci"}],"updated-by":[{"DOI":"10.1007\/s11606-014-2876-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,5,24]],"date-time":"2014-05-24T00:00:00Z","timestamp":1400889600000}}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-011-1966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-011-1966-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-011-1966-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T09:57:30Z","timestamp":1640512650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-011-1966-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,19]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1966"],"URL":"https:\/\/doi.org\/10.1007\/s11606-011-1966-4","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,19]]}}}